APA (7th ed.) Citation

S, N., K, S., T, K., H, K., A, F., S, T., . . . T, S. (2020). Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer. Dove Medical Press.

Chicago Style (17th ed.) Citation

S, Noguchi, Suminaga K, Kaki T, Kawachi H, Fukao A, Terashita S, Horikawa S, Ikeue T, and Sugita T. Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer. Dove Medical Press, 2020.

MLA (8th ed.) Citation

S, Noguchi, et al. Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer. Dove Medical Press, 2020.